Grand River Regional Cancer Centre
Kitchener, Ontario, Canada
Cancer treatment center in Kitchener, Ontario
835 King St W, Kitchener, ON N2G 1G3
About Grand River Regional Cancer Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
NCIC Clinical Trials Group
10
Ontario Clinical Oncology Group (OCOG)
10
National Cancer Institute (NCI)
8
Canadian Cancer Trials Group
7
Alliance for Clinical Trials in Oncology
4
Radiation Therapy Oncology Group
4
AGO Study Group
1
American College of Radiology Imaging Network
1
Amgen
1
Boehringer Ingelheim
1
Centre hospitalier de l'Université de Montréal (CHUM)
1
Clinical Trials at Grand River Regional Cancer Centre
During the past decade, Grand River Regional Cancer Centre conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 20 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
1999-12-14
2017-04-19
Completed
1,832
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
1999-09-01
2006-10-01
Completed
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
2001-08-31
2013-01-10
Completed
819
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
2002-08-08
2009-12-21
Completed
128
Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma
2001-05-08
2014-01-16
Completed
824
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Grand River Regional Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 10 trials, followed by "Ontario Clinical Oncology Group (OCOG)" with 10 trials
sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Canadian Cancer Trials Group" with 7 trials sponsored and "Alliance for Clinical Trials in Oncology"
with 7 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Grand River Regional Cancer Centre"
#1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 64 different institutions and companies that were
collaborators in the rest 55 trials.
Clinical Trials Conditions at Grand River Regional Cancer Centre
According to Clinical.Site data, the most researched conditions in "Grand River Regional Cancer Centre" are
"Breast Cancer" (11 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (3 trials), "Invasive Breast Carcinoma" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Grand River Regional Cancer Centre" in a lesser frequency.
Clinical Trials Intervention Types at Grand River Regional Cancer Centre
Most popular intervention types in "Grand River Regional Cancer Centre" are "Drug" (36 trials), "Other" (16 trials), "Radiation" (14 trials), "Biological" (11 trials) and "Procedure" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Quality-of-Life Assessment" (6 trials), "Laboratory Biomarker Analysis" (5 trials), "cetuximab" (4 trials) and "paclitaxel" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Grand River Regional Cancer Centre
The vast majority of trials in "Grand River Regional Cancer Centre" are
38 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Grand River Regional Cancer Centre
Currently, there are NaN active trials in "Grand River Regional Cancer Centre".
undefined are not yet recruiting,
8 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 32 completed trials in Grand River Regional Cancer Centre,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Grand River Regional Cancer Centre, 0 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".